Teva Pharmaceuticals USA recalls DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Sa
Recalled January 20, 2016 · FDA recall D-0566-2016 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing. · FDA Class II
Units
9,717 bottles
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications: High out of specification test result for impurities during stability testing.
Product
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE Tablets (Mixed Salts of a Single Entity Amphetamine Product), 10 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0972-02, UPC 3 0555-0972-02 0.
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →